Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...
Scientists from F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have patented NLRP3 inflammasome and interleukin-1β (IL1B; IL-1β) release inhibitors reported to be useful for the treatment of ...
Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...
Introduction: The pro-inflammatory cytokine interleukin-23 (IL-23 ... accessible at webgestalt.org was utilized with their default parameters. The input was a list of all genes sorted on fold change ...
Low dose interleukin 2 is being tested as an immunomodulatory approach in neurodegenerative diseases. It increases the number and activity of regulatory T cells (Tregs) that suppress inflammation. At ...
Inflammation is currently recognized as one of the major causes of premature delivery. As a member of the interleukin-1β (IL-1β) family, interleukin-33 (IL-33) has been shown to be involved in normal ...
interferon-γ (IFNγ), interleukin-1β (IL1β), IL2, IL4, IL6, IL8, IL10, IL12.p70, tumor necrosis factor- α (TNFα) and C-reactive protein. Briefly, the lyophilized cytokine standards and the serum ...
The correlation analysis indicated that the decreased hepcidin may have contributed to enhanced iron availability in HAPC, and decreased interleukin (IL)-10 and IL-22 were significantly associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results